Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DATOPOTAMAB DERUXTECAN-DLNK Cause Stomatitis? 27 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Stomatitis have been filed in association with DATOPOTAMAB DERUXTECAN-DLNK. This represents 16.4% of all adverse event reports for DATOPOTAMAB DERUXTECAN-DLNK.

27
Reports of Stomatitis with DATOPOTAMAB DERUXTECAN-DLNK
16.4%
of all DATOPOTAMAB DERUXTECAN-DLNK reports
3
Deaths
4
Hospitalizations

How Dangerous Is Stomatitis From DATOPOTAMAB DERUXTECAN-DLNK?

Of the 27 reports, 3 (11.1%) resulted in death, 4 (14.8%) required hospitalization.

Is Stomatitis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DATOPOTAMAB DERUXTECAN-DLNK. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does DATOPOTAMAB DERUXTECAN-DLNK Cause?

Disease progression (49) Off label use (31) No adverse event (22) Nausea (11) Prescribed underdose (9) Death (7) Interstitial lung disease (7) Dyspnoea (6) Mucosal inflammation (5) Product prescribing issue (5)

What Other Drugs Cause Stomatitis?

METHOTREXATE (7,245) TOCILIZUMAB (4,761) ADALIMUMAB (4,500) LEFLUNOMIDE (4,492) ABATACEPT (4,481) ETANERCEPT (4,338) RITUXIMAB (4,335) CERTOLIZUMAB PEGOL (3,760) INFLIXIMAB (3,713) PREDNISONE (3,656)

Which DATOPOTAMAB DERUXTECAN-DLNK Alternatives Have Lower Stomatitis Risk?

DATOPOTAMAB DERUXTECAN-DLNK vs DAUNORUBICIN DATOPOTAMAB DERUXTECAN-DLNK vs DAXIBOTULINUMTOXIN A-LANM DATOPOTAMAB DERUXTECAN-DLNK vs DAYTRANA DATOPOTAMAB DERUXTECAN-DLNK vs DECITABINE DATOPOTAMAB DERUXTECAN-DLNK vs DEFERASIROX

Related Pages

DATOPOTAMAB DERUXTECAN-DLNK Full Profile All Stomatitis Reports All Drugs Causing Stomatitis DATOPOTAMAB DERUXTECAN-DLNK Demographics